Bladder exstrophy-epispadias-cloacal exstrophy complex is the most severe form of the BEEC (Bladder exstrophy-epispadias complex), constituting 10% of all the cases. In this condition, an abdominal ...
BERLIN & COPENHAGEN, July 26, 2023--(BUSINESS WIRE)--MyoPax has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for its regenerative cell therapy in ...
Bladder exstrophy complex is a congenital anomaly characterised by eversion of the bladder through a defect in the lower abdominal wall, accompanied by varying degrees of pelvic bone separation, ...
Read by title at the annual meeting of the New England Surgical Society, Salem, Massachusetts, September 29-30, 1939. From the departments of surgery, Children's Hospital and Harvard Medical School, ...
MyoPax has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for its regenerative cell therapy in Exstrophy-Epispadias Complex (EEC). MyoPax aims to repair the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results